The S&P 500 climbed to a record high close on Wednesday and the Nasdaq Composite Index dipped as investors weighed upbeat vaccine developments and a potential coronavirus fiscal package against a bleak private jobs report.

Republicans and Democrats in Congress remained unable to reach agreement on fresh relief for a pandemic-hit U.S. economy, although some investors said bad economic news could spur policy makers to push harder for a deal.

U.S. House Majority Leader Steny Hoyer also expressed hope that a deal could be reached "in the next few days."

Signs of progress in the race to distribute a vaccine have driven U.S. stocks higher in recent days. In the latest upbeat development, Pfizer Inc and BioNTech's COVID-19 vaccine got the green light for use in Britain, the first Western country to approve a shot for COVID-19. Pfizer jumped 3.5% and BioNTech surged about 6%.

Underscoring the argument for fiscal stimulus, data showed private payrolls increased less than expected in November, likely as soaring new infections and business restrictions hampered the labor market's recovery.

Moreover, the Federal Reserve's Beige Book report showed "little or no growth" in four of the central bank's 12 U.S. districts and only modest growth elsewhere in recent weeks.

Any potential sign of a worsening labor market in Friday's broader jobs report could put more pressure on Congress to agree on a stimulus package, said Ross Mayfield, an investment strategy analyst at Baird.

"They are watching this stuff as much as investors are," Mayfield said. "It could be one of those reports where bad news is good news if it spurs the right stakeholders to come to the table."

Positive updates on coronavirus vaccine have helped investors raise bets on a swift economic rebound next year, powering the S&P 500 and Nasdaq to record highs on Tuesday.

A rotation into value stocks continued, with the S&P 500 financial index and energy index stocks gaining, while consumer staples dropped.

On Wall Street, the Dow Jones Industrial Average rose 59.87 points, or 0.2%, to 29,883.79; the S&P 500 gained 6.55 points, or 0.18%, to 3,669; and the Nasdaq Composite dropped 5.74 points, or 0.05%, to 12,349.37.

U.S. stock benchmarks closed at record highs on Tuesday.

The Nasdaq was dragged by a 2.7% slide in Tesla Inc.

Getting a generous stimulus package through Congress is a top priority, President-elect Joe Biden said in an interview with the New York Times. He also said he would not immediately cancel the Phase 1 trade deal that Trump struck with China.

The biggest drag on the blue-chip Dow was a nearly 9% slump in Salesforce.com Inc after the software company agreed to buy workplace messaging app provider Slack Technologies Inc in a $28 billion deal as it bets on an extended run for remote working. Slack fell more than 2%.

Cloud data service provider NetApp Inc's shares jumped 9% after it forecast third-quarter profit above expectations.

Advancing issues outnumbered decliners on the NYSE by a 1.46-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.

The S&P 500 posted 18 new 52-week highs and no new lows; the Nasdaq Composite recorded 89 new highs and 12 new lows.

Volume on U.S. exchanges was 11.6 billion shares, compared with the 11.7 billion average over the last 20 trading days.

GLOBAL MARKETS

World equity benchmarks hovered near record highs and the dollar hit fresh 2-1/2-year lows on Wednesday as investors weighed the first approval of a coronavirus vaccine and the prospects for more U.S. economic stimulus with disappointing American jobs data.

Britain approved Pfizer Inc's COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the first country to do so for the newly developed treatment. Inoculations should begin among the most vulnerable segments of its population early next week.

U.S. health officials have announced plans to start vaccinating Americans as early as mid-December, once regulatory approvals are in place.

"Early vaccines will help bolster the reflation and normalcy trade, which has been the key macro theme in driving equity markets," said Neil MacKinnon, global macro strategist at VTB Capital.

Yet, disappointing private jobs data in the United States kept a lid on gains and helped support safe-haven assets. Employers added 307,000 jobs last month, well below the 410,000 expected by economists polled by Reuters, according to the ADP National Employment Report.

The dollar index fell 0.104%, while U.S. benchmark 10-year notes last fell 3/32 in price to yield 0.9442%, up from 0.934% Tuesday.

MSCI's gauge of stocks across the globe gained 0.27% following modest gains in Asia and mixed trading in Europe.

"General risk sentiment is unchanged - perhaps there's a bit of consolidation today, but that's understandable given where we've come from since November," said Derek Halpenny, EMEA head of research for global markets at MUFG. The dollar lost more than 2.5% of its value in November.

Republicans and Democrats in Congress remained unable to agree on a support package for the pandemic-hit U.S. economy on Wednesday, with top Republicans supporting what the Senate's top Democrat dismissed as an "inadequate, partisan proposal."

Spot gold added 0.7% to $1,828.23 an ounce. U.S. gold futures gained 0.72% to $1,827.20 an ounce

Oil prices climbed on anticipation that the Organization of the Petroleum Exporting Countries (OPEC) will maintain production limits next year.

U.S. crude rose 1.3% to $45.13 per barrel and Brent was at $48.20, up 1.64% on the day.

Oil has raced up nearly 30% over the last month.